FBLD 2024 Presentation Slides
High-Throughput Activity-Based Fragment Screening with Ulysses®
Generating Robust Datasets for ML-Driven Drug Discovery
Unlock the full potential of your drug discovery programs with insights from Arctoris’ CEO Tom Fleming, presented at the 2024 Fragment-Based Lead Discovery (FBLD) Conference in Boston. The presentation dives deep into the transformative role of automation in accelerating lead discovery, leveraging cutting-edge high-throughput screening, and advancing fragment-based approaches in early-stage drug development.
What’s Inside:
- The future of drug discovery: Automation-driven
high-throughput screening (HTS) and its role in expediting lead identification. - Innovations in assay optimization to enhance data
quality and reduce variability. - Best practices for implementing fully automated
workflows in fragment-based lead discovery. - Case studies showcasing how Arctoris’ highly
scalable automated platforms deliver faster and more reliable drug discovery results.
Get Your Copy Now
Fill out the form to download our presentation and gain access to insights that could supercharge your drug discovery programs.
© 2024 Arctoris®
